Back

Association between Triglyceride-Glucose Index and Clinical Outcome in Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction.

Iwakura, K.; Okamura, A.; Iwanaga, Y.; Koyama, Y.; Tanaka, N.; Okada, M.; Seo, M.; Yamada, T.; Yano, M.; Hayashi, T.; Yasumura, Y.; Nakagawa, Y.; Tamaki, S.; Nakagawa, A.; Okada, K.; Sotomi, Y.; Hikoso, S.; Nakatani, D.; Sakata, Y.

2025-05-15 cardiovascular medicine
10.1101/2025.05.13.25327566 medRxiv
Show abstract

BackgroundAlthough insulin resistance (IR) is associated with a higher risk of incident heart failure (HF), it is not fully understood whether IR could affect clinical outcomes in patients with established HF. We investigated the relationship between the triglyceride-glucose (TyG) index, a simple surrogate marker for IR, and clinical outcomes in patients with HF with preserved ejection fraction (HFpEF). MethodsThis retrospective analysis from the PURSUIT-HFpEF registry included 917 patients hospitalized for decompensated HFpEF. The TyG index was calculated at discharge as ln(triglyceride [mg/dL] x fasting blood glucose [mg/dL]/2). The primary outcomes were all-cause death and major adverse cardiovascular events (MACEs; a composite of all-cause death, heart failure hospitalization, and stroke). ResultsThe median age of patients was 83 years, 44.7% was male, and 39.2% had diabetes. The median BMI was 21.5 kg/m{superscript 2}, with 20.9% having BMI <18.5 kg/m {superscript 2}. During a median follow-up of 387 days, 168 deaths and 343 MACEs occurred. A stepwise Cox hazard model revealed that higher TyG index was independently associated with lower risk of all-cause death (HR 0.53, 95% CI 0.38-0.75) and MACEs (HR 0.77, 95% CI 0.61-0.97). When patients were divided into quartiles based on TyG index, the incidences of both outcomes were significantly lower in higher TyG quartiles (all-cause death; p=0.0003, MACEs; p=0.007 by log-rank). ConclusionsIn this predominantly elderly, low BMI cohort with established HFpEF, higher TyG index was paradoxically associated with better clinical outcomes. These findings imply a complex relationship between IR and HFpEF outcomes. Clinical Perspective1) What is new?O_LIThe triglyceride-glucose (TyG) index is a novel, easily calculated surrogate marker for insulin resistance (IR) using only serum triglyceride and fasting blood glucose levels. C_LIO_LIA higher TyG index, reflecting greater IR, was paradoxically associated with a lower incidence of all-cause mortality and major adverse cardiovascular events in patients hospitalized with heart failure with preserved ejection fraction (HFpEF) over approximately one year of follow-up. C_LIO_LIThis association remained consistent across various subgroups stratified by age, sex, BMI, diabetes status, and other risk factors. C_LI 2) What are the clinical implications?O_LIA paradoxical relationship between IR and clinical outcomes may exist in predominantly older, low-BMI Japanese patients with established HFpEF. C_LIO_LIThe prognostic impact of IR in established heart failure appears complex and may vary depending on patient characteristics. C_LI

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.